Campbell; Patricia S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Campbell; Patricia S..The latest application filed is for "novel formulations for the administration of fluoxetine".

Company Profile

0.23.3

Campbell; Patricia S. - Palo Alto CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Formulations for the administration of fluoxetine Grant 7,011,844 - Gale , et al. March 14, 2	2006-03-14
Novel formulations for the administration of fluoxetine App 20050186277 - Gale, Robert M. ; et al.	2005-08-25
Novel formulations for transdermal delivery of pergolide App 20040209909 - Yum, Su Il ; et al.	2004-10-21
Novel formulations for the administration of fluoxetine App 20030166624 - Gale, Robert M. ; et al.	2003-09-04
Formulations for transdermal delivery of pergolide Grant 6,572,879 - Yum , et al. June 3, 2	2003-06-03
Formulations for the administration of fluoxetine Grant 6,512,010 - Gale , et al. January 28, 2	2003-01-28
Reduction of skin irritation during electrotransport delivery Grant 6,324,424 - Ledger , et al. November 27, 2	2001-11-27
Drug delivery devices and process of manufacture Grant 6,174,545 - Enscore , et al. January 16, 2	2001-01-16
Drug delivery devices and process of manufacture Grant 6,007,837 - Enscore , et al. December 28, 1	1999-12-28
Formulations for transdermal delivery of pergolide Grant 6,001,390 - Yum , et al. December 14, 1	1999-12-14
Composition and method of enhancing electrotransport agent delivery Grant 5,990,179 - Gyory , et al. November 23, 1	1999-11-23
Composition and method of enhancing electrotransport agent delivery Grant 5,985,316 - Gyory , et al. November 16, 1	1999-11-16
Transdermal drug delivery device having enhanced adhesion Grant 5,840,327 - Gale , et al. November 24, 1	1998-11-24
Reduction of skin irritation during electrotransport delivery Grant 5,693,010 - Ledger , et al. December 2, 1	1997-12-02
Oral sustained release drug delivery device Grant 5,512,293 - Landrau , et al. April 30, 1	1996-04-30
Subsaturated transdermal therapeutic system having improved release characteristics Grant 5,462,745 - Enscore , et al. * October 31, 1	1995-10-31
Subsaturated transdermal therapeutic system having improved release characteristics Grant 5,344,656 - Enscore , et al. * September 6, 1	1994-09-06
Subsaturated transdermal therapeutic system having improved release characteristics Grant 5,342,623 - Enscore , et al. * August 30, 1	1994-08-30
Subsaturated transdermal therapeutic system having improved release characteristics Grant 4,908,027 - Enscore , et al. March 13, 1	1990-03-13
Transdermal drug delivery device Grant 4,867,982 - Campbell , et al. * September 19, 1	1989-09-19
Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix Grant 4,832,953 - Campbell , et al. May 23, 1	1989-05-23
Transdermal contraceptive formulations Grant 4,816,258 - Nedberge , et al. March 28, 1	1989-03-28
Transdermal drug delivery device Grant 4,725,439 - Campbell , et al. February 16, 1	1988-02-16
Transdermal therapeutic system having improved delivery characteristics Grant 4,704,282 - Campbell , et al. November 3, 1	1987-11-03
Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer Grant 4,460,372 - Campbell , et al. July 17, 1	1984-07-17
Dosage for coadministering drug and percutaneous absorption enhancer Grant 4,379,454 - Campbell , et al. April 12, 1	1983-04-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.